The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review RFK Jr. and the Perils of Peptides Washington Monthly